EKF Diagnostics (LON:EKF) Shares Cross Below 200-Day Moving Average – Time to Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 25.66 and traded as low as GBX 25.30. EKF Diagnostics shares last traded at GBX 25.41, with a volume of 99,145 shares changing hands.

Analysts Set New Price Targets

Separately, Stifel Nicolaus reissued a “buy” rating and issued a GBX 35 price target on shares of EKF Diagnostics in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, EKF Diagnostics presently has an average rating of “Buy” and a consensus target price of GBX 35.

EKF Diagnostics Stock Performance

The stock has a market cap of £108.43 million, a PE ratio of 53.62 and a beta of 0.51. The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77. The business has a 50 day moving average price of GBX 26.24 and a two-hundred day moving average price of GBX 25.66.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.